Alnylam Pharmaceuticals
(ALNY)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2008 | 12-2007 | 09-2007 | 06-2007 | 03-2007 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -1,239 | -85,466 | -87,128 | -34,336 | -21,645 |
| Depreciation Amortization | 951 | 4,082 | 3,180 | 2,132 | 1,195 |
| Income taxes - deferred | -16 | 1,889 | 1,889 | N/A | N/A |
| Accounts receivable | -4,649 | -1,194 | -1,292 | -1,785 | -564 |
| Accounts payable and accrued liabilities | 5,258 | -264 | 2,968 | 1,583 | -1,079 |
| Other Working Capital | -13,893 | 252,151 | 266,896 | 858 | -645 |
| Other Operating Activity | 4,930 | 25,321 | 18,444 | 12,196 | 11,777 |
| Operating Cash Flow | $-8,658 | $196,519 | $204,957 | $-19,352 | $-10,961 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 103,189 | -261,140 | -178,526 | -20,999 | -48,498 |
| PPE Investments | -2,945 | -5,446 | -1,211 | -2,849 | -1,354 |
| Purchase Of Investment | N/A | -10,000 | -10,000 | N/A | N/A |
| Other Investing Activity | 0 | -839 | 0 | 0 | 0 |
| Investing Cash Flow | $100,244 | $-277,425 | $-189,737 | $-23,848 | $-49,852 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 957 | 957 | 957 | N/A |
| Debt Repayment | -915 | -3,333 | -2,441 | -1,569 | -775 |
| Common Stock Issued | 443 | 61,011 | 59,364 | 519 | 379 |
| Financing Cash Flow | $-472 | $58,635 | $57,880 | $-93 | $-396 |
| Exchange Rate Effect | 10 | -527 | -508 | -198 | -84 |
| Beginning Cash Position | 105,157 | 127,955 | 127,955 | 127,955 | 127,955 |
| End Cash Position | 196,281 | 105,157 | 200,547 | 84,464 | 66,662 |
| Net Cash Flow | $91,124 | $-22,798 | $72,592 | $-43,491 | $-61,293 |
| Free Cash Flow | |||||
| Operating Cash Flow | -8,658 | 196,519 | 204,957 | -19,352 | -10,961 |
| Capital Expenditure | -2,945 | -7,788 | -3,554 | -2,849 | -1,354 |
| Free Cash Flow | -11,603 | 188,731 | 201,403 | -22,201 | -12,315 |